fashion -WSS

fashion

author：entertainment 2025-10-02 11:09:10 - browse：1185

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： The aspartame in Diet Coke probably isn’t giving you cancer

focus

WSS

White House announces new plan to address the growing threat of xylazine in overdose crisis

Keeping primary care docs in field isn't impossible, says AAFP CEO

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Medicare wants to send $9 billion to 340B hospitals

SEC charges former device maker CEO with $41 million fraud

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

explore

fashion

hotspot

Jerome Adams on the need for new antivirals for Covid

Biden targets hefty hospital 'facility fees' that often surprise patients

New air purifier tech could be key to improving indoor air quality

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

How to save PrEP access — and even expand it

Hospitals owned by private equity see complications spike 25%

BioMarin wins approval for gene therapy to treat hemophilia A

CRISPR gene editing developments we’re watching in 2024

Alkermes shareholders re

Why health care costs have stayed mostly flat since 2010

focus

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Eisai exec who led development of Alzheimer’s drug to retire

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Medicare Advantage beneficiaries sue Humana over algorithm use

Three trends to watch in biotech in 2024

leisure time

explore

focus

knowledge